Events, Meetings & Webinars

Alterity Therapeutics to Participate in Two Investor Conferences

webinar meeting

Alterity Therapeutics (ASX: ATH,NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced that David Stamler, M.D., Chief Executive Officer will participate in two upcoming virtual investor events:

MST Financial Lifesciences & Biotech Fourm
Wednesday, November 24th at 5:20 p.m. PST (U.S.) / Thursday, November 25th at 12.20 pm AEST
A link to the live and recorded webcast will be available on the Alterity website.

Benchmark Company Discovery One-on-One Investor Conference
Thursday, December 2nd (U.S.) /  Friday, December 3rd (Australia)

Check Out The New Martech Cube Podcast. For more such updates, follow us on Google News Martech News

Previous ArticleNext Article